- Report
- January 2022
- 90 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Report
- January 2022
- 150 Pages
Global
From €1346EUR$1,500USD£1,158GBP
- Report
- January 2022
- 70 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Report
- January 2022
- 125 Pages
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- January 2022
- 90 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Report
- January 2022
- 125 Pages
Global
From €2243EUR$2,500USD£1,931GBP
- Report
- January 2022
- 90 Pages
Global
From €1795EUR$2,000USD£1,545GBP
- Report
- April 2020
- 150 Pages
Global
From €6236EUR$6,950USD£5,367GBP
- Report
- November 2023
- 160 Pages
Global
From €3229EUR$3,599USD£2,779GBP
- Report
- November 2023
- 160 Pages
Global
From €3229EUR$3,599USD£2,779GBP
- Report
- October 2023
- 158 Pages
Europe
From €3229EUR$3,599USD£2,779GBP
- Report
- October 2023
- 140 Pages
Global
From €3229EUR$3,599USD£2,779GBP
- Report
- October 2023
- 158 Pages
Latin America
From €3552EUR$3,959USD£3,057GBP
- Report
- April 2023
- 147 Pages
Global
From €4441EUR$4,949USD£3,822GBP
- Report
- October 2021
- 241 Pages
Global
From €4441EUR$4,949USD£3,822GBP
- Report
- May 2023
- 147 Pages
Global
From €4441EUR$4,949USD£3,822GBP
- Report
- February 2024
- 160 Pages
Global
From €4459EUR$4,969USD£3,837GBP
- Report
- December 2023
- 160 Pages
United States
From €2503EUR$2,789USD£2,154GBP
- Report
- September 2023
- 140 Pages
Global
From €3229EUR$3,599USD£2,779GBP
- Report
- September 2023
- 140 Pages
Global
From €3229EUR$3,599USD£2,779GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more